Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 20, 2017
Pharmacy Choice - Pharmaceutical News - Studies from University of Maryland School of Pharmacy Reveal New Findings on Medicare and Medicaid (Do Restrictions on Antipsychotic Use Differ... - October 20, 2017

Pharmacy News Article

 6/16/17 - Studies from University of Maryland School of Pharmacy Reveal New Findings on Medicare and Medicaid (Do Restrictions on Antipsychotic Use Differ...

Studies from University of Maryland School of Pharmacy Reveal New Findings on Medicare and Medicaid (Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?)

By a News Reporter-Staff News Editor at Insurance Weekly News Data detailed on Medicare and Medicaid have been presented. According to news reporting out of Baltimore, Maryland, by VerticalNews editors, research stated, "The objective of this study was to describe the type of restrictions and differences among antipsychotic users enrolled in Medicare Part D Stand-Alone (PDPs) and Advantage (MAPDs) prescription drug plans. This retrospective study used data from Chronic Condition Data Warehouse, comprising a random 5% sample of the Medicare population in 2008."

Our news journalists obtained a quote from the research from the University of Maryland School of Pharmacy, "This study used bivariate analyses and multivariate logistical regression models to study differences in formulary restrictions on antipsychotic use between PDP and MAPD enrollees, adjusting for enrollee characteristics. Dependent variables included type of restriction and antipsychotic therapeutic class. The study sample was restricted to continuous Part D enrollees (N=1,346,978) stratified by plan type, MAPDs (N=435,591), and PDPs (N=911,387). According to the bivariate analysis, antipsychotic users enrolled in PDPs were more likely to encounter restrictions (39.8%), compared with those in MAPDs (30.3%). In the multivariate analyses, antipsychotic users in MAPDs were less likely to face any restriction (odds ratio [OR]=0.75, 95% confidence interval [CI] 0.72-0.78). Furthermore, atypical antipsychotic users in MAPDs were less likely to face any restriction (OR=0.76, 95% CI 0.73-0.79), while first-generation antipsychotic users in MAPDs were more likely to face any restriction (OR=1.87, 95% CI 1.32-2.65). Low-income subsidy (LIS) beneficiaries using any antipsychotic were much more likely to face restrictions compared with non-LIS beneficiaries. PDP enrollees prescribed antipsychotics were more likely to face formulary restrictions, as opposed to those in MAPDs."

According to the news editors, the research concluded: "LIS beneficiaries enrolled in PDPs faced much higher risk of restricted access to this 'protected' drug class."

For more information on this research see: Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans? The Consultant Pharmacist, 2017;32(2):109-118.

Our news journalists report that additional information may be obtained by contacting J. Chou, Dept. of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, United States. Additional authors for this research include N.J. Brandt, F.E. Loh and B. Stuart.

Keywords for this news article include: Antipsychotics, Maryland, Baltimore, United States, Health Policy, Mental Health, Medicare and Medicaid, North and Central America.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Oct 23: Vitamin D Primer for Pharmacy Professionals
Oct 24: Metabolic Syndrome: The Heart of Any Wellness Practice
Oct 25: Dispensing Controlled Substances in Today’s Pharmacy
Oct 26: Management of Schizophrenia & Acute Agitation
Oct 27: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415